메뉴 건너뛰기
Ugeskrift for Laeger
Volumn 169, Issue 50, 2007, Pages 4360-4363
A meta-analysis of the efficacy and safety of the anti-obesity agent Rimonabant;Vurdering af effekt og sikkerhed ved rimonabant som farmakologisk behandling af adipositas
Author keywords

[No Author keywords available]
Indexed keywords

EID: 39449137781     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (24)
References (10)
  • 1
    • 17144382751 scopus 로고    scopus 로고
    • Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study
    • Van Gaal LF, Rissanen AM, Scheen AJ et al. Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study. Lancet 2005;365:1389-97.
    • (2005) Lancet , vol.365 , pp. 1389-1397
    • Van Gaal, L.F.1    Rissanen, A.M.2    Scheen, A.J.3
  • 2
    • 27844463517 scopus 로고    scopus 로고
    • Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia
    • Despres JP, Golay A, Sjostrom L. Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia. N Engl J Med 2005;353:2121-34.
    • (2005) N Engl J Med , vol.353 , pp. 2121-2134
    • Despres, J.P.1    Golay, A.2    Sjostrom, L.3
  • 3
    • 32644441249 scopus 로고    scopus 로고
    • Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial
    • Pi-Sunyer FX, Aronne LJ, Heshmati HM et al. Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial. JAMA 2006;295:761-75.
    • (2006) JAMA , vol.295 , pp. 761-775
    • Pi-Sunyer, F.X.1    Aronne, L.J.2    Heshmati, H.M.3
  • 4
    • 33751001942 scopus 로고    scopus 로고
    • Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: A randomised controlled study
    • Scheen AJ, Finer N, Hollander P et al. Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study. Lancet 2006;368:1660-72.
    • (2006) Lancet , vol.368 , pp. 1660-1672
    • Scheen, A.J.1    Finer, N.2    Hollander, P.3
  • 5
    • 33845874637 scopus 로고    scopus 로고
    • Drug treatments for obesity: Orlistat, sibutramine, and rimonabant
    • Padwal RS, Majumdar SR. Drug treatments for obesity: orlistat, sibutramine, and rimonabant. Lancet 2007;369:71-7.
    • (2007) Lancet , vol.369 , pp. 71-77
    • Padwal, R.S.1    Majumdar, S.R.2
  • 6
    • 84972545970 scopus 로고
    • A survey of exact inference for contingency tables
    • Agresti A. A survey of exact inference for contingency tables. Statistical Science 1992;7:131-77.
    • (1992) Statistical Science , vol.7 , pp. 131-177
    • Agresti, A.1
  • 7
    • 0037186429 scopus 로고    scopus 로고
    • Advanced methods in meta-analysis: Multivariate approach and meta-regression
    • Van Houwelingen HC, Arends LR, Stijnen T. Advanced methods in meta-analysis: multivariate approach and meta-regression. Stat Med 2002;21:589-624.
    • (2002) Stat Med , vol.21 , pp. 589-624
    • Van Houwelingen, H.C.1    Arends, L.R.2    Stijnen, T.3
  • 8
    • 0041876133 scopus 로고    scopus 로고
    • Measuring inconsistency in meta-analyses
    • Higgins JP, Thompson SG, Deeks JJ et al. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.
    • (2003) BMJ , vol.327 , pp. 557-560
    • Higgins, J.P.1    Thompson, S.G.2    Deeks, J.J.3
  • 10
    • 85003220340 scopus 로고    scopus 로고
    • Long-term pharmacotherapy for obesity and overweight
    • CD004094
    • Padwal R, Li S, Lau D. Long-term pharmacotherapy for obesity and overweight. Cochrane Database Syst Rev 2003;4:CD004094.
    • (2003) Cochrane Database Syst Rev , vol.4
    • Padwal, R.1    Li, S.2    Lau, D.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.